Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Nutrition | Research article

Association between awareness of nutrition labeling and high-density lipoprotein cholesterol concentration in cancer survivors and the general population: The Korean National Health and Nutrition Examination Survey (KNHANES) 2010–2016

Authors: Ji Sung Yoo, Kyu-Tae Han, Seung Hyun Chung, Eun-Cheol Park

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Nutrition labeling has been found to affect the amount and type of food intake, with certain groups in the population, such as cancer survivors, being more aware of this information. A higher awareness of nutrition labeling is inversely related to the risk of dyslipidemia. This study therefore assessed the association between awareness of nutrition labeling and high-density lipoprotein cholesterol (HDL-C) concentration among cancer survivors in South Korea and in the general population of subjects without a history of cancer.

Methods

This cross-sectional analysis evaluated 25,156 adults who participated in the Korean National Health and Nutrition Examination Surveys (KNHANES) from 2010 to 2016. Factors influencing the association between awareness of nutrition labeling and HDL-C concentration in cancer survivors and the general population were determined by multiple regression analysis.

Results

Of the 25,156 participants, 2.88% were cancer survivors and 97.12% had no history of cancer. HDL-C concentrations were higher in subjects who were aware of nutrition labeling than in subjects who were not. Checking or using nutrition labeling had a greater effect on the management of HDL-C concentration for cancer survivors than for the general population.

Conclusion

Awareness of nutrition labeling was associated with better outcomes, including higher controlled HDL-C levels, and reductions in factors increasing the risk of coronary artery disease and cancer, especially in cancer survivors. Health policymakers or medical professionals should develop programs to promote the use of nutrition labeling among cancer survivors in South Korea.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Community of Population-Based Regional Cancer R: Cancer statistics in Korea: incidence, mortality, survival, and Prevalence in 2014. Cancer research and treatment : official journal of Korean Cancer Association. 2017;49(2):292–305.CrossRef Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Community of Population-Based Regional Cancer R: Cancer statistics in Korea: incidence, mortality, survival, and Prevalence in 2014. Cancer research and treatment : official journal of Korean Cancer Association. 2017;49(2):292–305.CrossRef
2.
go back to reference Demark-Wahnefried W, Jones LW. Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am. 2008;22(2):319–42.CrossRef Demark-Wahnefried W, Jones LW. Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am. 2008;22(2):319–42.CrossRef
3.
go back to reference Pekmezi DW, Demark-Wahnefried W. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol. 2011;50(2):167–78.CrossRef Pekmezi DW, Demark-Wahnefried W. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol. 2011;50(2):167–78.CrossRef
4.
go back to reference Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–74.CrossRef Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–74.CrossRef
5.
go back to reference Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT, Snyder DC, Owzar K, Hars V, Albala DM. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiology and Prevention Biomarkers. 2008;17(12):3577–87.CrossRef Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT, Snyder DC, Owzar K, Hars V, Albala DM. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiology and Prevention Biomarkers. 2008;17(12):3577–87.CrossRef
6.
go back to reference Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III8–14.PubMed Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III8–14.PubMed
7.
go back to reference Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity. 2007;15(12):2875–88.CrossRef Rashid S, Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity. 2007;15(12):2875–88.CrossRef
8.
go back to reference Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol. 2010;55(25):2846–54.CrossRef Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol. 2010;55(25):2846–54.CrossRef
9.
go back to reference Park H-K. Nutrition policy in South Korea. Asia Pac J Clin Nutr. 2008;17(S1):343–5.PubMed Park H-K. Nutrition policy in South Korea. Asia Pac J Clin Nutr. 2008;17(S1):343–5.PubMed
10.
go back to reference Cowburn G, Stockley L. Consumer understanding and use of nutrition labelling: a systematic review. Public Health Nutr. 2005;8(1):21–8.CrossRef Cowburn G, Stockley L. Consumer understanding and use of nutrition labelling: a systematic review. Public Health Nutr. 2005;8(1):21–8.CrossRef
11.
go back to reference Campos S, Doxey J, Hammond D. Nutrition labels on pre-packaged foods: a systematic review. Public Health Nutr. 2011;14(8):1496–506.CrossRef Campos S, Doxey J, Hammond D. Nutrition labels on pre-packaged foods: a systematic review. Public Health Nutr. 2011;14(8):1496–506.CrossRef
12.
go back to reference Kim JY, Kweon KH, Kim MJ, Park E-C, Jang S-Y, Kim W, Han K-T. Is nutritional labeling associated with individual health? The effects of labeling-based awareness on dyslipidemia risk in a south Korean population. Nutr J. 2015;15(1):81.CrossRef Kim JY, Kweon KH, Kim MJ, Park E-C, Jang S-Y, Kim W, Han K-T. Is nutritional labeling associated with individual health? The effects of labeling-based awareness on dyslipidemia risk in a south Korean population. Nutr J. 2015;15(1):81.CrossRef
13.
go back to reference Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. data resource profile: the Korea National Health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77.CrossRef Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. data resource profile: the Korea National Health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77.CrossRef
14.
go back to reference Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen M-R, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington PJEhj: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) 2011, 32(14):1769–1818. Reiner Ž, Catapano AL, De Backer G, Graham I, Taskinen M-R, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington PJEhj: ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) 2011, 32(14):1769–1818.
15.
go back to reference Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67.CrossRef Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67.CrossRef
16.
go back to reference Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.CrossRef Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67(3):253–6.CrossRef
17.
go back to reference Jones LW, Demark-Wahnefried W. Diet, exercise, and complementary therapies after primary treatment for cancer. The Lancet Oncology. 2006;7(12):1017–26.CrossRef Jones LW, Demark-Wahnefried W. Diet, exercise, and complementary therapies after primary treatment for cancer. The Lancet Oncology. 2006;7(12):1017–26.CrossRef
18.
go back to reference Gordon DJ, Rifkind BM. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 1989;321(19):1311–6.CrossRef Gordon DJ, Rifkind BM. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 1989;321(19):1311–6.CrossRef
19.
go back to reference Toth PP. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Am J Cardiol. 2005;96(9):50–8.CrossRef Toth PP. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Am J Cardiol. 2005;96(9):50–8.CrossRef
20.
go back to reference Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. Journal of the National Cancer Institute. 2004;96(15):1152–60.CrossRef Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. Journal of the National Cancer Institute. 2004;96(15):1152–60.CrossRef
21.
go back to reference Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008;18(9):671–7.CrossRef Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol. 2008;18(9):671–7.CrossRef
22.
go back to reference Song S, Hwang E, Moon H-G, Noh D-Y, Lee JE. Adherence to guidelines for cancer survivors and health-related quality of life among Korean breast cancer survivors. Nutrients. 2015;7(12):10307–19.CrossRef Song S, Hwang E, Moon H-G, Noh D-Y, Lee JE. Adherence to guidelines for cancer survivors and health-related quality of life among Korean breast cancer survivors. Nutrients. 2015;7(12):10307–19.CrossRef
Metadata
Title
Association between awareness of nutrition labeling and high-density lipoprotein cholesterol concentration in cancer survivors and the general population: The Korean National Health and Nutrition Examination Survey (KNHANES) 2010–2016
Authors
Ji Sung Yoo
Kyu-Tae Han
Seung Hyun Chung
Eun-Cheol Park
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Nutrition
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5196-6

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine